Literature DB >> 31071690

An age-dependent series of eye models for radiation dosimetry.

Alireza Vejdani-Noghreiyan1, Atiyeh Ebrahimi-Khankook.   

Abstract

Several studies have been appeared, up to now, that indicate the effect of accurate simulation on dose received by different substructures of the eye, irradiated by external beams of short-range radiation such as electron. Different representations of the eye have consequently been introduced. Their accuracies depend on the purpose for which models are described or the degree of accuracy of information that models are based upon. All of developed models have presented the eye of an adult human, while the size, shape, and thickness of the eye substructures change with age. This work offers a series of age-dependent eye models including five models of different ages to investigate the influence of the individual age on doses to eye substructures. The absorbed dose conversion coefficients were calculated using Monte Carlo MCNP code for 17 monoenergetic broad electron beams in the range of 100 keV to 10 MeV and for 0°, 30° and 45° angles of incidence. Results showed the strong dependency of sclera and iris doses to the age (PDD above 105), for low-energies electrons. Increasing the electron energy, the PDD decreases severely for these substructure which means dose fluctuation in the age-dependent eye models reduces. For higher energies, dose fluctuations due to age become small and for some substructures could be negligible. Highlights - A series of age-dependent eye models was developed based on the realistic anatomy. - Dose conversion coefficients of eye substructures were calculated for each models. - 17 monoenergetic electron beams and three angles of incidence were considered. - Fluctuations of doses to eye sections due to the age were obtained.

Entities:  

Mesh:

Year:  2019        PMID: 31071690     DOI: 10.1088/1361-6560/ab2059

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  1 in total

1.  Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy.

Authors:  Xiaoping Yi; Yan Fu; Qianyan Long; Yazhuo Zhao; Sai Li; Chunhui Zhou; Huashan Lin; Xiaolian Liu; Chang Liu; Changyong Chen; Liangrong Shi
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.